BYAH

Park Ha Biological Technology Co., Ltd. BYAH

NasdaqSmall CapMaterials

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $2.5M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$2.52M

Quarter to Oct 31

Net income

$-24.36M

Quarter to Oct 31

Free cash flow

$-3.0K

Quarter to Oct 31

Top Institutional Holders

as of Q4 2025
$107.1K total
RENAISSANCE TECHNOLOGIES LLC
$54.2KNew
CITADEL ADVISORS LLC
$14.9KNew
XTX Topco Ltd
$11.8KNew
Virtu Financial LLC
$11.0KNew
JANE STREET GROUP, LLC
$5.9KNew
GEODE CAPITAL MANAGEMENT, LLC
$2.7KNew
StoneX Group Inc.
$2.5KNew
TWO SIGMA SECURITIES, LLC
$2.5KNew
MORGAN STANLEY
$996New
UBS Group AG
$569New
ROYAL BANK OF CANADA
$0New
See all 11 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2025
EDGAR

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Loading ratio trend…

BYAH key financials by period

Reported revenue, net income and operating margin by fiscal year, from Park Ha Biological Technology Co., Ltd.'s annual filings on SEC EDGAR.

Park Ha Biological Technology Co., Ltd. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$2.5M$-24.4M—
FY 2024$2.4M$478.6K33.3%
FY 2023$2.5M$852.0K48.0%
FY 2022$1.9M$191.3K10.3%
Source: BYAH filings on SEC EDGAR →

BYAH insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Park Ha Biological Technology Co., Ltd. (BYAH): stock profile, AI score and financials

Park Ha Biological Technology Co., Ltd. (BYAH) stock profile, AI quality score, and SEC EDGAR financial data, a Materials sector company. BYAH is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $2.5m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (FY 2025), Park Ha Biological Technology Co., Ltd. reports quarterly revenue of $2.5M, net income of $-24.4M, free cash flow of $-3.0K. Top institutional holders of BYAH by reported 13-F value include RENAISSANCE TECHNOLOGIES, CITADEL ADVISORS, XTX Topco Ltd, based on the most recent SEC filings. BYAH trades on the Nasdaq exchange and files with the SEC under CIK 1986247. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BYAH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Park Ha Biological Technology Co., Ltd. directly from SEC EDGAR.

SEC EDGAR: CIK 1986247 →